Vico Therapeutics Alternatives & Competitors
12 companies similar to Vico Therapeutics — Our mission is simple… bring innovative RNA modulating therapies to patients wit...
Companies similar to Vico Therapeutics
ADARx Pharmaceuticals Inc.
Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...
San Diego, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Praxis Precision Medicines, Inc.
The era of genetic neuroscience has arrived
Boston, United States
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Rival Readout
Competing with Vico Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ultragenyx
Going Beyond Every Day
Novato, United States
Dynacure
Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 prog...
Illkirch-graffenstaden, F...
Zenas BioPharma
Enabling patients with autoimmune diseases to reimagine life
Waltham, United States
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Chicago, United States
-Ltd.-logo. "CV6 Therapeutics, (NI) Ltd."){kind=logo}
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
United Kingdom
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Ractigen Therapeutics
Turn on genes and turn off diseases
Suzhou, China
About Vico Therapeutics
Vico Therapeutics is making strides in the Health Care and Pharmaceutical industries by focusing on innovative RNA modulating therapies for severe genetic neurological diseases. Founded in 2019 and based in The Netherlands, the company aims to address conditions like spinocerebellar ataxia types 3 and 1, and Huntington...
Development of Antisense Oligonucleotide Therapies, Clinical Trials for Genetic Disorders, Genetic Intervention Research
Patients with Rare Neurological Diseases, Caregivers, Advocacy Communities, Healthcare Providers specializing in Neurology
RNA Modulating Therapies, Genetic Neurological Diseases, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 1, Huntington’s Disease, Antisense Oligonucleotides, CNS Disorders, Rare Neurological Disorders, Ribonucleic Acid Therapies, Hereditary Ataxia, Neurodegenerative Disorders, Neurodevelopmental Disorders, VICOMER Platform, Rett Syndrome
B2B, B2B2B
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vico Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vico Therapeutics on 10 Jun 2026. The 12 companies listed here were last checked between 29 May 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
